RadNet (RDNT) PT Raised to $80 at Jefferies

Jefferies analyst Brian Tanquilut raised the price target on RadNet (NASDAQ: RDNT) to $80.00 (from $75.00) while maintaining a Buy rating.

The analyst comments "Inbound call volume on RDNT remains strong, and investors often ask why we remain bullish, and here's where we stand today: 1) RDNT's core imaging center business continues to perform solidly as it benefits from secular tailwinds and company-specific strategies (hospital JVs), 2) the upcoming rollout of DeepHealth OS should drive margin upside in '25, and 3) we see upcoming AI catalysts (prostate rollout, OEM contract) that should push the stock higher."

You May Also Be Interested In

• StoneX Reiterates Buy Rating on DoorDash Inc. (DASH)
• Arcus Biosciences (RCUS) PT Raised to $40 at Truist Securities
• Truist on Callaway Golf (CALY): 'A refocused strategy to be predictably on the fairway'